Literature DB >> 28254959

Telephone-supported computerised cognitive-behavioural therapy: REEACT-2 large-scale pragmatic randomised controlled trial.

Simon Gilbody1, Sally Brabyn2, Karina Lovell2, David Kessler2, Thomas Devlin2, Lucy Smith2, Ricardo Araya2, Michael Barkham2, Peter Bower2, Cindy Cooper2, Sarah Knowles2, Elizabeth Littlewood2, David A Richards2, Debbie Tallon2, David White2, Gillian Worthy2.   

Abstract

BackgroundComputerised cognitive-behavioural therapy (cCBT) for depression has the potential to be efficient therapy but engagement is poor in primary care trials.AimsWe tested the benefits of adding telephone support to cCBT.MethodWe compared telephone-facilitated cCBT (MoodGYM) (n = 187) to minimally supported cCBT (MoodGYM) (n = 182) in a pragmatic randomised trial (trial registration: ISRCTN55310481). Outcomes were depression severity (Patient Health Questionnaire (PHQ)-9), anxiety (Generalized Anxiety Disorder Questionnaire (GAD)-7) and somatoform complaints (PHQ-15) at 4 and 12 months.ResultsUse of cCBT increased by a factor of between 1.5 and 2 with telephone facilitation. At 4 months PHQ-9 scores were 1.9 points lower (95% CI 0.5-3.3) for telephone-supported cCBT. At 12 months, the results were no longer statistically significant (0.9 PHQ-9 points, 95% CI -0.5 to 2.3). There was improvement in anxiety scores and for somatic complaints.ConclusionsTelephone facilitation of cCBT improves engagement and expedites depression improvement. The effect was small to moderate and comparable with other low-intensity psychological interventions. © The Royal College of Psychiatrists 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28254959     DOI: 10.1192/bjp.bp.116.192435

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  25 in total

1.  Acceptability of mHealth augmentation of Collaborative Care: A mixed methods pilot study.

Authors:  Amy M Bauer; Matthew Iles-Shih; Reza Hosseini Ghomi; Tessa Rue; Tess Grover; Naomi Kincler; Monica Miller; Wayne J Katon
Journal:  Gen Hosp Psychiatry       Date:  2017-11-24       Impact factor: 3.238

Review 2.  The Use of Telemedicine and Mobile Technology to Promote Population Health and Population Management for Psychiatric Disorders.

Authors:  Carolyn Turvey; John Fortney
Journal:  Curr Psychiatry Rep       Date:  2017-10-16       Impact factor: 5.285

Review 3.  Guided Internet-Delivered Treatment for Depression: Scoping Review.

Authors:  Line Børtveit; Anders Dechsling; Stefan Sütterlin; Tine Nordgreen; Anders Nordahl-Hansen
Journal:  JMIR Ment Health       Date:  2022-10-04

Review 4.  Technology-supported strategies for promoting user engagement with digital mental health interventions: A systematic review.

Authors:  Daniel Z Q Gan; Lauren McGillivray; Mark E Larsen; Helen Christensen; Michelle Torok
Journal:  Digit Health       Date:  2022-06-01

Review 5.  Collaborative Care and Related Interventions in Patients With Heart Disease: An Update and New Directions.

Authors:  Jeff C Huffman; Caitlin N Adams; Christopher M Celano
Journal:  Psychosomatics       Date:  2017-09-18       Impact factor: 2.386

6.  The effect of depression and anxiety symptom severity on clinical outcomes and app use in digital mental health treatments: Meta-regression of three trials.

Authors:  David C Mohr; Mary J Kwasny; Jonah Meyerhoff; Andrea K Graham; Emily G Lattie
Journal:  Behav Res Ther       Date:  2021-09-24

7.  Banbury Forum Consensus Statement on the Path Forward for Digital Mental Health Treatment.

Authors:  David C Mohr; Francisca Azocar; Andrew Bertagnolli; Tanzeem Choudhury; Paul Chrisp; Richard Frank; Henry Harbin; Trina Histon; Debra Kaysen; Camille Nebeker; Derek Richards; Stephen M Schueller; Nickolai Titov; John Torous; Patricia A Areán
Journal:  Psychiatr Serv       Date:  2021-01-20       Impact factor: 4.157

8.  Internet-Based Cognitive Behavioral Therapy for Depression: A Systematic Review and Individual Patient Data Network Meta-analysis.

Authors:  Eirini Karyotaki; Orestis Efthimiou; Clara Miguel; Frederic Maas Genannt Bermpohl; Toshi A Furukawa; Pim Cuijpers; Heleen Riper; Vikram Patel; Adriana Mira; Alan W Gemmil; Albert S Yeung; Alfred Lange; Alishia D Williams; Andrew Mackinnon; Anna Geraedts; Annemieke van Straten; Björn Meyer; Cecilia Björkelund; Christine Knaevelsrud; Christopher G Beevers; Cristina Botella; Daniel R Strunk; David C Mohr; David D Ebert; David Kessler; Derek Richards; Elizabeth Littlewood; Erik Forsell; Fan Feng; Fang Wang; Gerhard Andersson; Heather Hadjistavropoulos; Heleen Christensen; Iony D Ezawa; Isabella Choi; Isabelle M Rosso; Jan Philipp Klein; Jason Shumake; Javier Garcia-Campayo; Jeannette Milgrom; Jessica Smith; Jesus Montero-Marin; Jill M Newby; Juana Bretón-López; Justine Schneider; Kristofer Vernmark; Lara Bücker; Lisa B Sheeber; Lisanne Warmerdam; Louise Farrer; Manuel Heinrich; Marcus J H Huibers; Marie Kivi; Martin Kraepelien; Nicholas R Forand; Nicky Pugh; Nils Lindefors; Ove Lintvedt; Pavle Zagorscak; Per Carlbring; Rachel Phillips; Robert Johansson; Ronald C Kessler; Sally Brabyn; Sarah Perini; Scott L Rauch; Simon Gilbody; Steffen Moritz; Thomas Berger; Victor Pop; Viktor Kaldo; Viola Spek; Yvonne Forsell
Journal:  JAMA Psychiatry       Date:  2021-04-01       Impact factor: 21.596

9.  Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients: A Randomized Clinical Trial.

Authors:  Andrea K Graham; Carolyn J Greene; Mary J Kwasny; Susan M Kaiser; Paul Lieponis; Thomas Powell; David C Mohr
Journal:  JAMA Psychiatry       Date:  2020-09-01       Impact factor: 21.596

10.  The development and validation of a prognostic model to PREDICT Relapse of depression in adult patients in primary care: protocol for the PREDICTR study.

Authors:  Andrew S Moriarty; Lewis W Paton; Kym I E Snell; Richard D Riley; Joshua E J Buckman; Simon Gilbody; Carolyn A Chew-Graham; Shehzad Ali; Stephen Pilling; Nick Meader; Bob Phillips; Peter A Coventry; Jaime Delgadillo; David A Richards; Chris Salisbury; Dean McMillan
Journal:  Diagn Progn Res       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.